Keywords: Phytochemicals; Silver nanoparticle; Green synthesis; Characterization; Biomedical
Silver nanoparticles are one of the most commonly utilized nanomaterial in medical biology due to their high electrical and thermal conductivity, optical properties as well as anti-microbial properties [7-12]. It is an established fact that silver compounds are very effective as antibacterial agents for both aerobic and anaerobic strains of bacteria. The reason behind the superior antibacterial properties of Ag NPs is due to the formation of free radicals from the surface of Ag and subsequent free radical induced membrane damage [13-21]. In the field of therapeutics, silver nanoparticles has been widely and commonly used as an important agent for wound healing probably through collagen alignment [22,23].
Medicinal plants are considerably useful and economically essential. They contain active constituents that are used in the treatment of many human diseases [24]. Among the various categories of compounds synthesized in plants, phytochemicals (primary and secondary metabolism products, such as antioxidants, flavonoids, flavones, isoflavones, catechins, anthocyanidins, isothiocyanates, carotenoids, and polyphenols) are the most potent materials for biological activities and are known as important natural resources for the synthesis of metallic nanoparticles [25]. In plant bioaccumulation, the localization of nanoparticles is based on the presence of particular enzymes or proteins involved in it. The recovery of these nanoparticles from plant tissues is tedious and expensive and needs enzymes to degrade the cellulosic materials, which surrounds it [26]. Thus, the synthesis of various metal nanoparticles using plant extracts is easy in downstream processing and in scaling up of nanoparticles [27-32].
Saraca asoca (Roxb.), one of the folk medicinal plants found in India, Bangladesh and Sri Lanka, belongs to family Caesalpiniaceae. A large number of primary and secondary metabolites like flavonoids, terpenoids, saponins, phenol, tannin, lignin, cardiac glycosides, and proteins are present in different parts of the plant [33]. The bark of Ashoka tree is used as antihypertensive in Dysmenorrhoea. It is haemorrhoidic, menorrhagic, leucorrhoeic, hemostatic, anticonvulsant and diuertic. It is also useful in menorrhagia due to uterine fibroids, in leucorrhea and in internal bleeding [34,35].
In the present study an attempt has been made for the synthesis of silver nanoparticles by reducing the silver ions in solution of silver nitrate with aqueous bark extract of Saraca asoca. The phytochemicals-coating of the surface of green nanomaterials was characterized and were tested for toxicity in mouse model and for their antimicrobial efficacy in vitro.
The plant extract was dissolved in methanol [1:10] and filtered with HPLC method and analyzed in GC-MS for different components. Identification of Components Interpretation on mass spectrum GC-MS was conducted using the database of National Institute Standard and Technology (NIST) having more than 62,000 patterns. The spectrum of the unknown component was compared with the spectrum of the known components stored in the NIST library. The name, molecular weight and structure of the components of the test materials were ascertained.
Acute toxicity study: Using the up and down procedure the acute oral toxicity of colloidal Ag NPs was tested in mice [36]. At a dose of 5,000 mg/ kg, colloidal AgNPs was administered orally in the mice of either sex. The animals were then observed continuously for determination of any toxic symptoms for first 3 hr after AgNPs administration. Finally, after 24 hours the number of survived mice was counted and animals were then maintained for 14 days for further observation. At 1, 7 and 14 days after gavages, five mice in each group were sacrificed.
Hematological analysis: For hematological analysis whole blood was collected from the experimental group of mice and different clinical parameters including Serum Glutamic Oxaloacetic Transaminase (SGOT), Serum Glutamic Pyruvic Transaminase (SGPT), serum creatinine, triglyceride, and total protein was tested.
Histopathological analysis: Major organs such as liver, kidney, spleen and heart were collected by sacrificing animals (three animals from each group were selected randomly) for histopathological analysis. The samples were then fixed immediately in 10% formal saline. Collected tissues were then dehydrated in graded concentrations of xylene and embedded in molten paraffin wax. Tissues were then sectioned at 5m thick. Tissue sections were fixed on glass slides and stained with hematoxylin and eosin for microscopic observation.
Assay of bactericidal activity: Bactericidal activity of the AgNPs was appraised by the standard disc diffusion method with 6mm diameter Whatman No.1 filter paper discs [37]. Metallic nanoparticles have bactericidal properties and exhibit increased chemical activity. This is due to their large surface to volume ratios and crystallographic surface structure. In this method 10 μl, 25 μl and 50 μl of silver nanoparticles (suspension of 1 mg/ ml) prepared from bark extract was added with 1 ml of distilled water and applied to sterile paper discs of 6mm diameter. Standard antibiotic discs (ampicillin and tetracycline 10 mg/ ml) were used for control. Nutrient agar and LB agar was used for the antimicrobial test. Before the antibacterial assay the bacteria Escherichia Coli and Pseudomonas aeruginosa (gram negative bacteria); Bacillus subtilis and Staphylococcus aureus (gram positive bacteria) were inoculated into the LB and nutrient agar medium respectively and agar plates are incubated at 37°C for 24 hours. Inhibition of zone was measured after 24-48 hour of inhibition.
Statistical analysis: Results from Table 3, 4 and 5 were presented as mean ± Standard Deviation (SD). Data were analyzed using analysis of variance (ANOVA; Tukey' Multiple Comparison Method). Values of P < 0.05 were considered as the level statistical significance. Statistical analysis was performed using the SPSS statistical software.
It is well known that the silver nanoparticles in aqueous colloidal solution exhibit yellowish brown color due to excitation of surface plasmon variation in silver nanoparticles. As the bark extract of Saraca asoca was mixed with aqueous solution of silver nitrate it started to change from pale yellow to reddish brown color due to reduction of silver ions indicating the formation of silver nanoparticles. Reduction of silver ion and the change in color has been frequently observed by several authors who successfully synthesized silver nanoparticles using different biomaterial [38-40]. In case of control experiment where bark extract was not added to silver nitrate solution exhibited no change in color even left for one week duration.
SL NO. |
RT |
Name of the compound |
Molecular formula |
Molecular weight |
Molecular structure |
1. |
5.18 |
3,5- dithiahexanol 5,5-hexanol |
C4H10O3S2 |
170 |
|
2. |
6.79 |
3,4-dimithoxy-dl-phenylalanine |
C11H15NO4 |
225 |
|
3. |
7.65 |
2-(allyloxy)-1,5-ditert-butyl-3-chlorobenzene |
C17H25ClO |
280 |
|
4. |
7.78 |
2,4,5-trichlorophenyl methyl sulphoxide |
C7H5Cl3O5 |
242 |
|
5. |
13.04 |
Meso-1,2-dimethoxy-1,2-bis(p-methoxyphenyl)ethane |
C18H22O4 |
302 |
|
6. |
14.18 |
2-benzylidenecyclootanone semicarbazone |
C16H21N3O |
271 |
|
7. |
16.56 |
1,3-dioxolane, 2-(5,5,5-trichloro-3-penten-1-yl)-, (E)- |
C8H11Cl3O2 |
244 |
|
8. |
18.58 |
1,3,5-triazine,2,4-dichloro-6-phenyl- |
C9H5Cl2N3 |
225 |
|
9. |
24.16 |
Phenol,2,4-di-tert-butyl- |
C14H22O |
206 |
|
10. |
25.71 |
(-)-dibenzoyl-L-tartaric acid |
C18H14O8 |
358 |
|
End RT |
Area |
%Area |
Height |
%Height |
2.26 |
399310 |
75.64 |
270635.1 |
86.18 |
2.65 |
66263.98 |
12.55 |
29615.1 |
9.43 |
5.2 |
8022.362 |
1.52 |
5737.496 |
1.83 |
24.35 |
49274.05 |
9.33 |
4967.284 |
1.58 |
45.33 |
5021.332 |
0.95 |
3064.413 |
0.98 |
It is generally recognized that UV-Visible spectroscopy could be used to examine the size and shape of nanoparticles in aqueous solution [42,43]. The reduction of silver ions and formation of stable nanoparticles occurred in a concentration as well as temperature dependent reaction. Because of the
instability of synthesized silver nanoparticles an optimum temperature is needed for the completion and settlement of the reduction reaction. It was observed that the optimal temperature of reaction mixture for conversion was 45°C and the SPR peaks became sharper with increase in optical density of the yellowish brown solution after 30 min of stirring depending on increasing temperature from 25°C to 45°C [Figure 2B,2C]. The absorption band at 433 nm showed the formation of silver
Day |
Group |
RBC |
Hb |
Ht |
MCV |
MCH |
MCHC |
PLT |
WBC |
Lymp |
Mono |
Granular |
(×106) |
(g/dl) |
(%) |
(×m-3) |
(pg) |
(g/dl) |
(× 103 mm–3) |
(×103) |
(× 103) |
(× 103) |
(× 103) |
||
1 |
Control |
|||||||||||
Male |
5.94 ± 0.36 |
10.98 ± 0.28 |
34.09 ± 1.34 |
54.41 ± 2.21 |
17.74 ± 0.67 |
32.85 ± 0.62 |
464.98 ± 0.65 |
2.06 ± 0.29 |
0.42 ± 0.08 |
6.62 ± 0.06 |
2.02 ± 0.21 |
|
Female |
6.26 ± 0.30 |
11.14 ± 0.28 |
33.55 ± 1.83 |
53.62 ± 1.37 |
17.42 ± 0.77 |
32.81 ± 0.78 |
510.21 ± 0.65 |
2.69 ± 0.27 |
0.47 ± 0.01 |
0.69 ± 0.02 |
1.83 ± 0.17 |
|
1 |
AgNPs |
|||||||||||
Male |
6.74 ± 0.92 |
11.64 ± 0.42 |
34.70 ± 1.72 |
55.69 ± 2.54 |
17.61 ± 0.74 |
31.44 ± 0.78 |
516.6 ± 69.09 |
2.40 ± 0.40 |
0.39 ± 0.03 |
0.43 ± 0.042 |
2.2 ± 0.27 |
|
Female |
5.66 ± 0.47 |
12.15 ± 0.79 |
35.89 ± 1.08 |
54.03 ± 1.02 |
17.27 ± 0.68 |
31.43 ± 0.5 |
479.4 ± 82.07 |
2.2 ± 0.40 |
0.41 ± 0.03 |
0.41 ± 0.07 |
1.92 ± 0.66 |
|
7 |
Control |
|||||||||||
Male |
6 ± 0.33 |
10.5 ± 0.81 |
34.26 ± 2.15 |
53.66 ± 1.94 |
17.25 ± 0.81 |
32.533 ± 1.12 |
528.6 ± 128.76 |
2.52 ± 0.65 |
0.33 ± 0.05 |
0.47 ± 0.18 |
1.5 ± 0.15 |
|
Female |
5.4 ± 0.83 |
10.02 ± 0.79 |
30.61 ± 1.47 |
55.12 ± 2.32 |
17.86 ± 0.43 |
33.5 ± 1.87 |
478.4 ± 79.44 |
2.60 ± 0.42 |
0.46 ± 0.03 |
0.36 ± 0.03 |
1.68 ± ± 0.17 |
|
7 |
AgNPs |
|||||||||||
Male |
5.56 ± 0.55 |
11.30 ± 1.04 |
32.11 ± 2.06 |
53.55 ± 3.00 |
17.75 ± 0.59 |
32.86 ± 0.93 |
515.8 ± 94.26 |
2.52 ± 0.43 |
0.29 ± 0.11 |
0.35 ± 0.11 |
2.1 ± 0.6 |
|
Female |
6.71 ± 0.86 |
10.62 ± 1.12 |
33.50 ± 2.88 |
47.77 ± 2.01 |
17.70 ± 0.76 |
31.50 ± 1.05 |
497.4 ± 87.22 |
2.14 ± 0.58 |
0.33 ± 0.13 |
0.40 ± 0.09 |
2.2 ± 0.84 |
|
14 |
Control |
|||||||||||
Male |
5.92 ± 0.92 |
10.90 ± 1.01 |
32.71 ± 1.83 |
53.67 ± 3.12 |
17.92 ± 0.78 |
32.16 ± 0.73 |
477.62 ± ± 127.35 |
2.28 ± 0.70 |
0.41 ± 0.10 |
0.40 ± 0.07 |
1.62 ± 0.23 |
|
Female |
5.78 ± 0.74 |
11.27 ± 1.61 |
35.9 ± 4.06 |
54.34 ± 3.06 |
17.64 ± 0.52 |
32.48 ± 0.87 |
511.18 ± 115.14 |
2.56 ± 0.46 |
0.37 ± 0.08 |
0.37 ± 0.05 |
2.18 ± 0.55 |
|
14 |
AgNPs |
|||||||||||
Male |
5.58 ± 0.74 |
10.38 ± 1.22 |
29.46 ± 1.69 |
55.22 ± 1.24 |
17.25 ± 0.67 |
31.84 ± 0.63 |
507.49 ± 86.78 |
2.18 ± 0.84 |
0.6 ± 0.08 |
0.41 ± 0.07 |
1.50 ± 0.42 |
|
Female |
5.8 ± 0.71 |
10.58 ± 0.83 |
31.34 ± 1.81 |
52.43 ± 2.23 |
16.91 ± 0.45 |
30.9 ± 0.51 |
486.61 ± 114.78 |
2.2 ± 0.81 |
0.38 ± 0.10 |
0.42 ± 0.05 |
1.47 ± 0.76 |
Differences with P < 0.05 are considered statistically significant.
a) RBC: red blood cell. Hb: hemoglobin concentration. Ht: hematocrit. MCV: mean corpuscular volume. MCH: mean corpuscular hemoglobin. MCHC:
mean corpuscular hemoglobin concentration. PLT: platelets. WBC: white blood cell. Lymp: lymphocyte. Mono: monocyte. Granular: granular cells.
Day |
Group |
Creatinine |
Triglyceride |
SGOTa |
SGPTb |
Total Protein |
1 |
Control |
|||||
Male |
0.6 ± 0 |
220.4 ± 6.87 |
86.52 ± 17.67 |
38.83 ± 14.94 |
5.06 ± 0.41 |
|
Female |
0.6 ± 0 |
155.4 ± 25.01 |
96.2 ± 22.62 |
33.49 ± 11.77 |
4.72 ± 0.29 |
|
1 |
AgNPs |
|||||
Male |
0.6 ± 0 |
211.03 ± 27.56 |
95.03 ± 21.90 |
31.91 ± 13.19 |
5.1 ± 0.3 |
|
Female |
0.5 ± 0.1 |
179.69 ± 37.19 |
106.31 ± 53.21 |
35.33 ± 15.24 |
4.8 ± 0.2 |
|
7 |
Control |
|||||
Male |
0.5 ± 0 |
210.62 ± 63.03 |
86.43 ± 13.62 |
27.62 ± 4.65 |
5 ± 0.1 |
|
Female |
0.6 ± 0.1 |
147.98 ± 27.68 |
66.22 ± 17.41 |
15.64 ± 3.72 |
5.1 ± 0.2 |
|
7 |
AgNPs |
|||||
Male |
0.6 ± 0.1 |
197.4 ± 48.09 |
128.2 ± 94.69 |
89.38 ± 30.74 |
5.2 ± 0.3 |
|
Female |
0.6 ± 0.1 |
142.58 ± 16.64 |
109.94 ± 35.59 |
19.3 ± 4.7 |
5.3 ± 0.1 |
|
14 |
Control |
|||||
Male |
0.6 ± 0 |
224.3 ± 49.1 |
72.3 ± 25.3 |
23.2 ± 14.5 |
5.1 ± 0.3 |
|
Female |
0.6 ± 0.1 |
112.2 ± 18.2 |
63.4 ± 21.3 |
25.2 ± 8.2 |
5.2 ± 0.1 |
|
14 |
AgNPs |
|||||
Male |
0.5 ± 0.1 |
232.3 ± 52.03 |
81.3 ± 32.01 |
27.3 ± 9.6 |
5 ± 0.1 |
|
Female |
0.6 ± 0 |
169.32 ± 21.3 |
67.3 ± 15.5 |
20.3 ± 1.5 |
5.2 ± 0.1 |
Differences with P < 0.05 are considered statistically significant.
a) SGOT: Serum Glutamic Oxaloacetic Transaminase.
b) SGPT: Serum Glutamic Pyruvic Transaminase.
Name of the bacterial species |
Amount of silver nanoparticles 1mg/ml |
Zone of inhibition Silver nanoparticles |
Zone of inhibition Standard drug |
E. coli |
10 μl 25 μl 50 μl |
5 ± 0.03 7.2 ± 0.10 8 ± 0.02 mm |
20 mm |
Bacillus subtilis |
10 μl 25 μl 50 μl |
11 ± 0.05 mm 14.22 ± 0.11 15 ± 0.14 |
19 mm |
S. aureus |
10 μl 25 μl 50 μl |
14 ± 0.11 mm 17.12 ± 0.12 17.11 ± 1.02 |
18 mm |
P. aeruginosa |
10 μl 25 μl 50 μl |
4.2 ± 0.01 7 ± 0.05 mm 7.12 ± 1.04 |
22 mm |
(A) Using different molar ratio of Ag and reductant (bark extract).
(B) Using different time of exposure C. Using different temperature D. UV spectra of final preparation of AgNPs.
From the analysis of FTIR studies we also confirmed that the carbonyl group from the amino acid residues and proteins has the stronger ability to bind metal surfaces. It was indicated that the metal nanoparticles were protected by the proteins which could possibly capped of silver nanoparticles to prevent agglomeration and thereby stabilize the particle size. These studies also suggested that the biological molecules could possibly perform dual functions of formation and stabilization of silver nanoparticles in the aqueous medium.
In all acute toxicity tests, no death was recorded in the 14 days of observation period in all control and treated animals. The animals did not show any significant changes in the general appearance during the observation period. There were no significant differences in the percentage of weight gain between the control and treatment groups of both male and female mice given 5,000 mg/ kg of the colloidal AgNPs orally (data not shown).
Hematology and clinical chemistry: The hematological analysis in acute oral toxicity test showed no significant changes of RBC, Hb%, Ht, MCV, MCH, MCHC, number of platelets and WBC in the male and female treatment groups compared to the control groups. The leukocyte differential count showed no significant difference between the control and treated groups [Table 3]. There were no significant differences in any of the biochemical parameters examined in either the control or treated group of the male and female mice [Table 4].
Histopathology: Histopathological study showed no significant gross changes in tissue histology. The tissue architecture of major organs such as Liver, Kidney, Spleen and Heart seemed to be similar in both control and treated group of animals.
The bactericidal mechanism of silver nanoparticles is only partially understood till date. Based on studies that shows that silver nanoparticles anchor to and penetrate the cell wall of Gram-negative bacteria [51, 52] It is reasonable to suggest that the resultant structural change in the cell membrane could cause an increase in cell permeability, leading to an uncontrolled transport through the cytoplasmic membrane, and ultimately cell death. Microorganisms have developed drug resistance over many generations. Different antimicrobial agents based on chemicals show efficacy in therapy; but its use as medical device in prophylaxis in antimicrobial facilities is limited and therefore, an alternative way is needed desperately to overcome the drug resistance of various microorganisms, especially in medical devices, etc. Ag salts and Ag+ ions have been used as antimicrobial agents in various fields because of their growth-inhibitory property against microorganisms. But for several reasons these ions have limited usefulness. The main reason is the interfering
• The size and shape of silver nanoparticles could be changed by altering concentration of bark extract as well as temperature which were confirmed by UV-vis spectroscopy and AFM analysis.
• The morphological features represents that the particles synthesized as a mixture of silver nanoprisms and spheres. At lower concentration of extract the mixture shows different shapes of Ag nanoparticles.
• The possible reducing agents are terpenoids and flavonoids. The capping material for stabilization includes proteins present in the bark extract.
• The preliminary in vivo toxicological data reveals that the synthesized nanoparticles have no significant hazardous effect on body system which will be further confirmed on cell toxicity assays using different in vitro cell line model in near future.
• The overall result shows that bark extract of saraca asoca can mediate the biosynthesis of silver nanoparticles efficiently. This green chemistry approach toward the synthesis of silver nanoparticles has many advantages. Possible applications of such eco- friendly and nontoxic nanoparticles in bactericidal, wound healing, drug delivery vehicles and other medical appliances will make this method potentially exciting for the large- scale synthesis of other inorganic nanoparticles.
- Bastys V, Pastoriza-Santos I, Rodríguez-González B, Vaisnoras R, Liz- Marzán L M. Formation of Silver Nanoprisms with Surface Plasmons at Communication Wavelengths. Adv Funct Mater. 2006; 16(6): 766- 773.
- Zhang J, Liu Z, Han B, Liu D, Chen J, He J, et al. Novel Method to Synthesize Polystyrene nanospheres Immobilized with Silver Nanoparticles by Using Compressed CO2. Chemistry. 2004; 10: 3531.
- Dahl JA, Maddux BL, Hutchison JE. Toward greener nanosynthesis. Chem Rev. 2007; 107: 2228-2269.
- Evanoff DD Jr, Chumanov G. Synthesis and optical properties of silver nanoparticles and arrays. Chemphyschem. 2005; 6: 1221-1231.
- Kang YS, Kang SW, Kim H, Won J, Kim CK, Char K, et al. Interaction with Olefins of the Partially Polarized Surface of Silver Nanoparticles Activated by p-Benzoquinone and Its Implications for Facilitated Olefin Transport. Adv Mater 2007; 19: 475-479.
- Ma H, Jiao Y, Yin B, Wang S, Zhao S, Huang S, et al. Spontaneous organization of individual silver nanoparticles into one-dimensionally ordered nanostructures. Chemphyschem. 2004; 5: 713-716.
- Johnson CJ, Zhukovsky N, Cass AE, Nagy JM. Proteomics, nanotechnology and molecular diagnostics. Proteomics. 2008; 8: 715- 730.
- Qiu L, Franc J, Rewari A, Blanc D, Saravanamuttu K. Photolytic formation of Ag nanoparticles in oligomeric organosiloxanes: new photolithographic routes to metallodielectric microperiodic structures J Mater Chem 2009;19:373-376.
- Campelo JM, Luna D, Luque R, Marinas JM, Romero AA. Sustainable preparation of supported metal nanoparticles and their applications in catalysis. ChemSusChem. 2009; 2: 18-45.
- Rondinini S, Aricci G, Krpetic Z, Locatelli C, Minguzzi A, Porta F, Vertova A Fuel cells 2008 (Early View, No. 0), 1.
- Davis JR. Metals Hand book desk 2nd ed. ASM International, Handbook Committee. San Jose, CA; 1998. P. 658.
- Lin J, Chen R, Feng S, Pan J, Li Y, Chen G, et al. A novel blood plasma analysis technique combining membrane electrophoresis with silver nanoparticle-based SERS spectroscopy for potential applications in noninvasive cancer detection. Nanomed Nanotech Biol and Med. 2011; 7(5): 655-663. doi: 10.1016/j.nano.2011.01.012.
- Kim JS, Kuk E, Yu KN, Kim JH, Park SJ, Lee HJ, et al. Antimicrobial effects of silver nanoparticles. Nanomedicine. 2007; 3: 95-101.
- Brandt O, Mildner M, Egger A E, Groessl M, Rix U, Posch M, et al. Nanoscalic silver possesses broad-spectrum antimicrobial activities and exhibits fewer toxicological side effects than silver sulfadiazine. Nanomed Nanotech Biol Med. 2012; 8(4): 478-488. doi: 10.1016/j. nano.2011.07.005.
- Mohanty S, Mishra S, Jena P, Jacob B, Sarkar B, Sonawane A. An investigation on the antibacterial, cytotoxic, and antibiofilm efficacy of starch-stabilized silver nanoparticles. Nanomedicine. 2012; 8(6): 916-924. doi: 10.1016/j.nano.2011.11.007.
- Nanda A, Saravanan M. Biosynthesis of silver nanoparticles from Staphylococcus aureus and its antimicrobial activity against MRSA and MRSE. Nanomedicine. 2009; 5: 452-456.
- Gajbhiye M, Kesharwani J, Ingle A, Gade A, Rai M. Fungus-mediated synthesis of silver nanoparticles and their activity against pathogenic fungi in combination with fluconazole. Nanomedicine. 2009; 5(4): 382-386. doi: 10.1016/j.nano.2009.06.005.
- Fayaz AM, Balaji K, Girilal M, Yadav R, Kalaichelvan PT, Venketesan R. Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against gram-positive and gram-negative bacteria. Nanomedicine. 2010; 6: 103-109.
- Dar M A, Ingle A, Rai M. Enhanced antimicrobial activity of silver nanoparticles synthesized by Cryphonectria sp. evaluated singly and in combination with antibiotics Nanomedicine. 2013; 9(1): 105-110. doi: 10.1016/j.nano.2012.04.007.
- Strydom SJ, Rose WE, Otto DP, Liebenberg W, de Villiers MM. Poly (amidoamine) dendrimer-mediated synthesis and stabilization of silver sulfonamide nanoparticles with increased antibacterial activity. Nanomedicine. 2013; 9(1): 85-93. doi: 10.1016/j.nano.2012.03.006.
- Gao H, Liu C, Jeong HE, Yang P. Plasmon-enhanced photocatalytic activity of iron oxide on gold nanopillars. ACS Nano. 2012; 6: 234-240.
- Kwan K H L, Liu X L, To M K T, Yeung K W K, Ho C M, Wong K K Y. Modulation of collagen alignment by silver nanoparticles results in better mechanical properties in wound healing. Nanomed Nanotech Biol and Med. 2011; 7(4): 497-504. doi: 10.1016/j.nano.2011.01.003.
- Tse C, Zohdy MJ, Ye JY, O'Donnell M, Lesniak W, Balogh L. Enhanced optical breakdown in KB cells labeled with folate-targeted silverdendrimer composite nanodevices. Nanomedicine. 2011; 7(1): 97- 106. doi: 10.1016/j.nano.2010.09.003.
- Stary F, Hans S (1998) The National guides to medical herbs and plants Tiger Books. Int. Plc. UK
- Park SY, Murphy SP, Wilkens LR, Henderson BE, Kolonel LN. Multivitamin use and the risk of mortality and cancer incidence: the multiethnic cohort study. Am J Epidemiol. 2011; 173: 906-914.
- Marshall AT, Haverkamp RG, Davies CE, Parsons JG, Gardea-Torresdey JL, van Agterveld D. Accumulation of gold nanoparticles in Brassic juncea. Int J Phytoremediation. 2007; 9: 197-206.
- Gardea-Torresdey JL, Gomez E, Peralta-Videa JR, Parsons JG, Troiani H, Jose Yacaman M. Alfalfa sprouts: a natural source for the synthesis of silver nanoparticles. Langmuir. 2003; 19(4): 1357-1361.
- Gardea-Torresdey JL, Parsons JG, Dokken K, Peralta-Videa J R, Troiani H, Santiago P, Jose-Yacaman M, et al. Formation and growth of Au nanoparticles inside live alfalfa plants. Nano Lett. 2002; 2: 397-401.
- Shankar SS, Rai A, Ankamwar B, Singh A, Ahmad A, Sastry M. Biological synthesis of triangular gold nanoprisms. Nat Mater. 2004; 3: 482-488.
- Rai A, Singh A, Ahmad A, Sastry M. Role of halide ions and temperature on the morphology of biologically synthesized gold nanotriangles. Langmuir. 2006; 22: 736-741.
- Mukunthan KS, Elumalai EK, Patel TN, Murty VR. Catharanthus roseus: a natural source for the synthesis of silver nanoparticles. Asian Pac J Trop Biomed. 2011; 1: 270-274.
- Satishkumar M, Sneha K, Won SW, Kim S, Yun YS. Cinnamon zeylanicum bark extract and powder mediated green synthesis of nano crystalline silver particles and its bactericidal activity. Colloids Surf B Biointerfaces. 2009; 73(2): 332-338. doi: 10.1016/j. colsurfb.2009.06.005.
- Suja M, Rajan S, Thirunalasundari T, Jana B, Thenmozhi S. Pharmacognostical and phytochemical studies of An Ayurvedic drug Saraca asoca stem bark. J Pharm Res. 2012; 5(2): 1119-1121.
- Jana B, Thenmozhi S, Suja M, Rajan S, Thirunalasundari T. Pharmacognostical and phytochemical studies of An Ayurvedic drug Saraca asoca stem bark. J Pharma. 2012; 5(2-5): 1119-1121.
- Saha S, Mukhopadhyay MK, Ghosh PD, Nath D. Effect of Methanolic Leaf Extract of Ocimum basilicum L. on Benzene-Induced Hematotoxicity in Mice. Evid Based Complement Alternat Med. 2012; 2012:176385. doi: 10.1155/2012/176385.
- Witthawaskul P, Panthong A, Kanjanapothi D, Taesothikul T, Lertprasertsuke N. Acute and subacute toxicities of the saponin mixture isolated from Schefflera leucantha Viguier. J Ethnopharmacol. 2003; 89: 115-121.
- Becerro MA, Lopez NI, Turon X, Uriz MJ. Antimicrobial activity and surface bacterial film in marine sponges. J Exp Mar Biol Ecol. 1994; 179(2): 195-205.
- Saxena A, Tripathi RM, Singh RP. Biological Synthesis of silver nanoparticles by using Onion (Allium cepa) extract and their antibacterial activity. Dig J Nanomater Bios. 2010; 5(2): 427-432.
- Vigneshwaran N, Kathe AA, Varadarajan PV, Nachane RP, Balasubramanya RH. Biomimetics of silver nanoparticles by white rot fungus, Phaenerochaete chrysosporium. Colloids Surf B Biointerfaces. 2006; 53: 55-59.
- Khandelwal N, Singh A, Jain D, Upadhyay MK, Verma HN. Green synthesis of silver nanoparticles using Argimone mexicana leaf extract and Evaluation of their antimicrobial activities. Dig J Nanomater Bios. 2010; 5: 483-489.
- Vaidyanathan R, Kalishwaralal K, Gopalram S, Gurunathan S. Nanosilver--the burgeoning therapeutic molecule and its green synthesis. Biotechnol Adv. 2009; 27: 924-937.
- Amendola V, Meneghetti M. Size evaluation of Gold Nanoparticles by UV-vis Spectroscopy. J Phys Chem C. 2009; 113(11): 4277-4288.
- Haiss W, Thanh NT, Aveyard J, Fernig DG. Determination of size and concentration of gold nanoparticles from UV-vis spectra. Anal Chem. 2007; 79: 4215-4221.
- Goia DV. Preparation and formation mechanisms of uniform metallic particles in homogeneous solutions. J. Mater. Chem. 2004; 14: 451- 458.
- Medina-Ramirez I, Bashir S, Luo Z, Liu JL. Green synthesis and characterization of polymer-stabilized silver nanoparticles. Colloids Surf B Biointerfaces. 2009; 73: 185-191.
- Prathna TC, Chandrasekaran N, Raichur AM, Mukherjee A. Biomimetic synthesis of silver nanoparticles by Citrus limon (lemon) aqueous extract and theoretical prediction of particle size. Colloids Surf B Biointerfaces. 2011; 82: 152-159.
- Kasthuri J, Veerapandian S, Rajendiran N. Biological synthesis of silver and gold nanoparticles using apiin as reducing agent. Colloids Surf B Biointerfaces. 2009; 68: 55-60.
- Ocwieja M, Morga M, Adamczyk Z. Self-assembled silver nanoparticles monolayers on mica-AFM, SEM, and electrokinetic characteristics. J Nanopart Res. 2013; 15(3): 1460.
- Sujitha M V, Kannan S. Green synthesis of gold nanoparticles using Citrus fruits (Citrus limon, Citrusreticulata and Citrus sinensis) aqueous extract and its characterization Spectrochimica Acta Part A Mol Biomol Spectrosc 2013; 102: 15–23. doi: 10.1016/j.saa.2012.09.042.
- OECD. 2001. Test guideline 425. Acute Oral toxicity test: up and down procedure. In: OECD guidelines for the testing of chemicals. Paris, France: Organization for Economic Cooperation and Development. Organization for Economic Cooperation & Development (OECD)
- Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramírez JT, et al. The bactericidal effect of silver nanoparticles. Nanotechnology. 2005; 16: 2346-2353.
- Sondi I, Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci. 2004; 275: 177-182.
- Lee HJ, Teo SY, Jeong SH. Antibacterial effect of nanosized silver colloidal solution on textile fabrics. 2003. J Mater Sci. 38: 2199-2204.
- Shrivastava S, Bera T, Roy A, Singh G, Ramachandrarad P, Dash D. Characterization of enhanced antibacterial effects of novel silver nanoparticles Nanotech 2007; 18:225103.